Longboard Pharmaceuticals, Inc.
USD59.98
CEO
Kevin R. Lind
IPO Date
2021-03-12
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Day Low
$59.98
Day High
$59.98
52W Low
$59.98
52W High
$59.98
Market Cap
$2.34B
| -1.3 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -26.8% | -25.5% | 0.01 | 19.91 | -3.0 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -27.1% | -25.6% | 0.00 | 17.66 | -20.4 |
| -13.8 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -4.8% | -4.6% | 0.01 | 31.43 | -12.4 |
| 31 Dec 2023 | Q4 | 87.5% | -187912.5% | -36.7% | -29.7% | 0.01 | 5.14 | -2.4 |
| 30 Sept 2023 | Q3 | 0.0% | 0.0% | -24.9% | -22.0% | 0.01 | 8.69 | -2.5 |
| 30 Jun 2023 | Q2 | 0.0% | 0.0% | -25.8% | -22.6% | 0.01 | 8.30 | -2.8 |
| 31 Mar 2023 | Q1 | 0.0% | 0.0% | -15.2% | -13.7% | 0.01 | 10.91 | -1.9 |
| 31 Dec 2022 | Q4 | 0.0% | 0.0% | -17.8% | -15.5% | 0.01 | 7.97 | -1.3 |
| 30 Sept 2022 | Q3 | 0.0% | 0.0% | -15.7% | -14.0% | 0.01 | 9.79 | -1.4 |
| 30 Jun 2022 | Q2 | 0.0% | 0.0% | -13.7% | -12.6% | 0.00 | 11.95 | -1.2 |